Dynavax Technologies Corp. (DVAX)
15.70
+0.02
(+0.16%)
USD |
NASDAQ |
Jan 13, 16:00
15.75
+0.04
(+0.29%)
After-Hours: 20:00
Dynavax Technologies Research and Development Expense (Annual): 61.55M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Merck & Co., Inc. | 15.79B |
| Amicus Therapeutics, Inc. | 109.36M |
| Agios Pharmaceuticals, Inc. | 295.63M |
| Hyperion DeFi, Inc. | 13.35M |
| Edgewise Therapeutics, Inc. | 124.90M |